Caricamento...

Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanoma

BACKGROUND: Indoleamine 2,3-dioxygenase (IDO) and survivin have been identified as potential targets for cancer vaccination. In this phase II study a vaccine using the peptides Sur1M2 and IDO5 was combined with the chemotherapy temozolomide (TMZ) for treatment of metastatic melanoma patients. The ai...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Stem Cell Investig
Autori principali: Nitschke, Nikolaj Juul, Bjoern, Jon, Iversen, Trine Zeeberg, Andersen, Mads Hald, Svane, Inge Marie
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2017
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5639040/
https://ncbi.nlm.nih.gov/pubmed/29057249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/sci.2017.08.06
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !